The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 424.40
Bid: 421.80
Ask: 422.20
Change: 50.20 (13.42%)
Spread: 0.40 (0.095%)
Open: 404.00
High: 428.40
Low: 401.40
Prev. Close: 374.20
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of President and CEO of QinetiQ US

17 Jan 2022 07:00

RNS Number : 5554Y
QinetiQ Group plc
17 January 2022
 

News release

QinetiQ Group plc

Shawn Purvis appointed President and CEO of QinetiQ US

17 January 2022 - QinetiQ Group plc ("QinetiQ" or "the Group") today names Shawn Purvis as President and CEO of QinetiQ US, effective 16 February 2022.

Shawn is currently a member of the Executive Leadership Team and Corporate Vice President at Northrop Grumman Corporation. Shawn leads Northrop Grumman's Enterprise Services sector, responsible for global cyber security, operations and next generation digitisation including digital design for engineering, production and manufacturing operations. Over the course of Shawn's 25+ years of P&L responsibilities, she has led billion-dollar organisations in the areas of defence, intelligence and cyber security technical solutions in support of the warfighter and intelligence customers both domestic and global, achieving organic revenue growth and margin improvement year over year. Her experience also includes the functional integration of a multi-billion dollar acquisition. As CEO of QinetiQ US, Shawn will be responsible for the complete operations of the business while transforming QinetiQ US into a world class provider of innovative defence and security solutions.

Shawn's extensive experience includes strategic, financial, engineering, operations and customer focused leadership positions within Lockheed Martin, Science Applications International Corporation (SAIC) and Northrop Grumman. Shawn holds a Master of Science (MSc) in Information Systems and was named as one of the Top 25 Executives to Watch in 2020/2021 by Washington Exec and a first time WASH100 winner in 2021. Shawn will join QinetiQ's Global Leadership Team led by Steve Wadey, QinetiQ's Group CEO and also join the QinetiQ Inc. Board.

Neil Johnson, Chairman of QinetiQ, commented:

"On behalf of the QinetiQ Group plc Board, I am very pleased to welcome Shawn to the Group. Shawn brings extensive executive level experience both in leading complex P&L organisations in the US and in integrating substantial businesses successfully. She has a proven track record for delivering programme execution, strategy and growth, and will be a significant asset to the leadership team."

Steve Wadey, Group CEO of QinetiQ, commented:

"With more than 25 years of experience in the US defence and intelligence industry and a track record of transformational leadership, driving P&L performance of complex organisations and large scale acquisition integration, Shawn is the right leader to build our disruptive mid-tier company in the US by supporting and protecting the US warfighter. Shawn's proven leadership skills are perfectly aligned to delivering both our short-term operational and financial performance and realising our long-term ambition to more than double the size of our US business over the next 5 years."

 Shawn Purvis, incoming President and CEO of QinetiQ US, commented:

"I am incredibly honoured and excited to be given the opportunity to lead the talented and dedicated people who make up our QinetiQ US business, as we continue to deliver mission critical sensing and robotic capabilities for the US warfighter. With an ambition to build a disruptive mid-tier company in the US through both organic growth and strategy-led acquisitions, I am focused on driving both strong operational performance and executing on our growth strategy for the medium and long-term."

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFLFDMEESEFF
Date   Source Headline
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDelivering growth in the US with $45m contract win
5th Aug 20226:22 pmRNSProposed Acquisition of Avantus Federal LLC
1st Aug 20223:19 pmRNSHolding(s) in Company
21st Jul 20223:18 pmRNSResult of AGM
21st Jul 20227:00 amRNSFirst Quarter Trading Update
19th Jul 20225:24 pmRNSHolding(s) in Company
12th Jul 20222:09 pmRNSHolding(s) in Company
12th Jul 20221:47 pmRNSDirector/PDMR Shareholding
29th Jun 20225:09 pmRNSDirector/PDMR Shareholding
27th Jun 202212:35 pmRNSHolding(s) in Company
15th Jun 20229:53 amRNSHolding(s) in Company
13th Jun 202212:59 pmRNSDirector/PDMR Shareholding
13th Jun 202212:28 pmRNSAnnual Financial Report
6th Jun 202210:52 amRNSHolding(s) in Company
30th May 202212:03 pmRNSNotification of Major Shareholding
23rd May 20227:00 amRNSConfirmation of Full Year Results
19th May 20227:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.